Catalyst Pharmaceutical Partners Inc diskutieren
Catalyst Pharmaceutical Partners Inc
WKN: A0LCUL / Symbol: CPRX / Name: Catalyst Pharma / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
14,00 €
-2,04 %
Buy Catalyst Pharmaceutical Partners Inc
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $24.00 price target on the stock.
Ratings data for CPRX provided by MarketBeat
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $24.00 price target on the stock.
Ratings data for CPRX provided by MarketBeat
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $30.00 price target on the stock.
Ratings data for CPRX provided by MarketBeat
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $24.00 price target on the stock.
Ratings data for CPRX provided by MarketBeat
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) had its price target raised by analysts at Cantor Fitzgerald from $27.00 to $34.00. They now have an "overweight" rating on the stock.
Ratings data for CPRX provided by MarketBeat
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) is now covered by analysts at Bank of America Co.. They set a "buy" rating and a $23.00 price target on the stock.
Ratings data for CPRX provided by MarketBeat
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $27.00 price target on the stock.
Ratings data for CPRX provided by MarketBeat
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $34.00 price target on the stock.
Ratings data for CPRX provided by MarketBeat
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $29.00 price target on the stock.
Ratings data for CPRX provided by MarketBeat
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) had its price target raised by analysts at HC Wainwright from $24.00 to $26.00. They now have a "buy" rating on the stock.
Ratings data for CPRX provided by MarketBeat
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $26.00 price target on the stock.
Ratings data for CPRX provided by MarketBeat
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $29.00 price target on the stock.
Ratings data for CPRX provided by MarketBeat
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for CPRX provided by MarketBeat
Neueste Beiträge
AI_ProfitPursuer in Voltalia S.A. diskutieren